Coronary stents are small expandable tubes that are used to treat narrowed or blocked coronary arteries and reduce chest pain (angina). Patients with coronary artery disease (CAD) are treated with these stents. These types of stents are also called as cardiac stents and consist of metallic mesh. These coronary stents are implanted in narrowed coronary artery during percutaneous coronary intervention (PCI). Research Beam Model: Research Beam Product ID: 1548262 5370 USD New
Coronary Stents Market - Global Opportunity Analysis and Industry Forecast, 2014-2022
 
 

Coronary Stents Market by Product (Drug-eluting Stent, Bare-metal Stent, and Bioabsorbable Vascular Stent), Biomaterials {Metallic (Cobalt Chromium, Platinum Chromium, Nickel Chromium, and Stainless Steel), Polymeric, and Natural Biomaterials), End User (Hospital & Clinic and Ambulatory Surgical Centers) - Global Opportunity Analysis and Industry Forecast, 2014-2022

  • Category : Medical Devices
  • Published On : April   2017
  • Pages : 151
  • Publisher : Allied Market Research
 
 
 

Coronary stents are small expandable tubes that are used to treat narrowed or blocked coronary arteries and reduce chest pain (angina). Patients with coronary artery disease (CAD) are treated with these stents. These types of stents are also called as cardiac stents and consist of metallic mesh. These coronary stents are implanted in narrowed coronary artery during percutaneous coronary intervention (PCI).

Increase in incidence of CAD, emergence of innovative coronary stents, and improved clinical outcomes due to stenting drive the market growth. In addition, rise in incidence of chronic & lifestyle diseases, especially diabetes and obesity, and improved insurance & reimbursement supplement the market growth. However, availability of alternative methods for coronary heart disease treatment and high cost of treatment-associated coronary stents hamper the market growth. Furthermore, the untapped emerging countries present lucrative opportunities for the market. The global coronary stents market accounted for $4,806 million in 2015, and is anticipated to reach at $9,003 million by 2022, registering a CAGR of 9.5% from 2016 to 2022.

The global coronary stents market is segmented based on product, biomaterial, end user, and geography. Based on product, it is classified into drug-eluting stent, bare-metal stent, and bio-absorbable vascular stent. On the basis of biomaterial, it is categorized into metallic, polymeric, and natural biomaterial. Metallic stents are further classified to cobalt chromium (CoCr), platinum chromium (Pt-Cr), stainless steel, and nickel titanium. Based on end user, it is divided into hospital & clinic and ambulatory surgical centers.

Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Asia-Pacific accounted for the highest market share in the coronary stents market in 2015, and is expected to retain its dominance throughout the forecast period, owing to the increase in demand for advanced healthcare services in emerging countries (India and China). In addition, with the withdrawal of Johnson & Johnson’s stents business in 2011, the market players from China and other Asia-Pacific countries have got an opportunity to accelerate in the global market. However, LAMEA is expected to emerge as a lucrative area with maximum growth potential, owing to the improvement in healthcare facilities, available disposable income, and rapid development in economic conditions.

Product development is the key strategy adopted by the market players. The report provides a comprehensive analysis of the key players that operate in the global coronary stents market.

KEY MARKET BENEFITS

  • The study provides an in-depth analysis of the global coronary stents market and the current trends and future estimations to elucidate the imminent investment pockets from 2014 to 2022.
  • The report presents quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on product type assists in understanding the trends in the industry.
  • Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the industry.

Coronary Stents Market Key Segments:

By Product

  • Drug-Eluting Stent
  • Bare-Metal Stent
  • Bio-absorbable Vascular Stent

By Biomaterial

  • Metallic
    • Cobalt Chromium (CoCr)
    • Platinum Chromium (Pt-Cr)
    • Stainless Steel
    • Nickel Titanium
  • Polymeric Biomaterial
  • Natural Biomaterial

By End User

  • Hospital & Clinic
  • Ambulatory Surgical Centers

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Egypt
    • Rest of LAMEA

KEY PLAYERS PROFILED

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Microport Scientific Corporation
  • Terumo Corporation
  • Medtronic plc.
  • Biotronik SE & Co. KG
  • Biosensors International Group, Ltd.
  • Stentys SA

Other players in the value chain include (profiles not included in the report)

  • Meril Life Sciences Pvt. Ltd.
  • Vascular Concepts Limited
  • Translumina GmbH
  • REVA Medical, Inc.
  • Elixir Medical Corporation

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.1. Top winning strategies

3.2.1.1. Competitive intelligence of companies and their strategies

3.2.2. Market share analysis, 2016

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Emergence of newer trend in the field of coronary stents
3.3.1.2. Improved clinical outcomes with stenting
3.3.1.3. Rise in prevalence of coronary heart disease
3.3.1.4. Improved insurance and reimbursement

3.3.2. Restraints

3.3.2.1. Availability of alternative treatment methods for coronary heart disease
3.3.2.2. High cost of treatment associated with stent implants
3.3.2.3. Stringent approval process for stents

3.3.3. Opportunities

3.3.3.1. Huge market opportunities in the developing countries

3.4. PORTERS FIVE FORCES ANALYSIS

3.4.1. Bargaining power of buyers
3.4.1. Bargaining power of suppliers
3.4.2. Threat of substitutes
3.4.3. Threat of new entrants
3.4.4. Competitive rivalry

3.5. CLINICAL TRIALS

CHAPTER 4 GLOBAL CORONARY STENTS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. DRUG-ELUTING STENTS (DES)

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast

4.3. BARE-METAL CORONARY STENTS

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.1. Market size and forecast

4.4. BIOABSORBABLE STENTS

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.1. Market size and forecast

CHAPTER 5 GLOBAL CORONARY STENT MARKET, BY BIOMATERIALS

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. METALLIC BIOMATERIALS

5.2.1. Market size and forecast

5.3. POLYMERIC BIOMATERIALS

5.3.1. Market size and forecast

5.4. NATURAL BIOMATERIALS

5.4.1. Market size and forecast

CHAPTER 6 GLOBAL CORONARY STENTS MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. AMBULATORY SURGICAL CENTERS

6.3.1. Market size and forecast

CHAPTER 7 GLOBAL CORONARY STENTS MARKET, BY GEOGRAPHY

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S. market size and forecast
7.2.5. Canada market size and forecast
7.2.6. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany market size and forecast
7.3.5. France market size and forecast
7.3.6. Italy market size and forecast
7.3.7. Spain market size and forecast
7.3.8. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan market size and forecast
7.4.5. China market size and forecast
7.4.6. India market size and forecast
7.4.7. Australia market size and forecast
7.4.8. Malaysia market size and forecast
7.4.9. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil market size and forecast
7.5.5. South Africa market size and forecast
7.5.6. South Arabia market size and forecast
7.5.7. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. ABBOTT LABORATORIES

8.1.1. Overview
8.1.2. Operating business segments
8.1.3. Business performance
8.1.4. Key strategic moves and developments

8.2. B. BRAUN MELSUNGEN AG.

8.2.1. Company overview
8.2.2. Operating business segments
8.2.3. Business performance
8.2.4. Key strategic moves and developments

8.3. BIOSENSORS INTERNATIONAL GROUP, LTD.

8.3.1. Overview
8.3.2. Operating business segments
8.3.3. Business performance
8.3.4. Key strategic moves and developments

8.4. BIOTRONIK SE & CO. KG

8.4.1. Company overview
8.4.2. Operating business segments
8.4.3. Key strategic moves and developments

8.5. BOSTON SCIENTIFIC CORPORATION

8.5.1. Overview
8.5.2. Operating business segments
8.5.3. Business performance
8.5.4. Key strategic moves and developments

8.6. C. R. BARD, INC.

8.6.1. Company overview
8.6.2. Operating business segments
8.6.3. Business performance
8.6.4. Key strategic moves and developments

8.7. MEDTRONIC PLC.

8.7.1. Overview
8.7.2. Operating business segments
8.7.3. Business performance
8.7.4. Key strategic moves and developments

8.8. MICROPORT SCIENTIFIC CORPORATION

8.8.1. Company Overview
8.8.2. Operating business segments
8.8.3. Business performance
8.8.4. Key strategic moves and developments

8.9. STENTYS SA

8.9.1. Company overview
8.9.2. Operating business segments
8.9.3. Business performance
8.9.4. Key strategic moves and developments

8.10. TERUMO CORPORATION

8.10.1. Overview
8.10.2. Operating business segments
8.10.3. Business performance
8.10.4. Key strategic moves and developments

LIST OF TABLES

TABLE 1. PREVALENCE OF CORONARY HEART DISEASE IN INDIA (2010-2015)
TABLE 2. GLOBAL CORONARY STENTS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 3. GLOBAL DRUG-ELUTING STENTS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 4. GLOBAL BARE-METAL STENTS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 5. GLOBAL BIOABSORBALE STENTS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 6. GLOBAL CORONARY STENTS MARKET, BY BIOMATERIALS, 2014-2022 ($MILLION)
TABLE 7. GLOBAL METALLIC BIOMATERIALS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 8. GLOBAL POLYMERIC BIOMATERIALS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 9. GLOBAL NATURAL BIOMATERIALS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 10. GLOBAL CORONARY STENTS MARKET, BY END USER, 2014-2022
TABLE 11. GLOBAL HOSPITALS MARKET, BY REGION, 2014-2022
TABLE 12. GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, 2014-2022
TABLE 13. GLOBAL CORONARY STENTS MARKET, BY REGIONS, 2014-2022 ($MILLION)
TABLE 14. NORTH AMERICA CORONARY STENTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 15. NORTH AMERICA CORONARY STENTS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 16. NORTH AMERICA CORONARY STENTS MARKET, BY BIOMATERIALS 2014-2022 ($MILLION)
TABLE 17. NORTH AMERICA CORONARY STENTS MARKET, BY END USER 2014-2022 ($MILLION)
TABLE 18. COMPETITIVE LANDSCAPE IN EUROPE
TABLE 19. EUROPE CORONARY STENTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 20. EUROPE CORONARY STENTS MARKET, BY PRODUCT 2014-2022 ($MILLION)
TABLE 21. EUROPE CORONARY STENTS MARKET, BY BIOMATERIALS 2014-2022 ($MILLION)
TABLE 22. EUROPE CORONARY STENTS MARKET, BY END USER 2014-2022 ($MILLION)
TABLE 23. ASIA-PACIFIC CORONARY STENTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 24. ASIA-PACIFIC CORONARY STENTS MARKET, BY PRODUCT 2014-2022 ($MILLION)
TABLE 25. ASIA-PACIFIC CORONARY STENTS MARKET, BY BIOMATERIALS 2014-2022 ($MILLION)
TABLE 26. ASIA-PACIFIC CORONARY STENTS MARKET, BY END USER 2014-2022 ($MILLION)
TABLE 27. LAMEA CORONARY STENTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 28. LAMEA CORONARY STENTS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 29. LAMEA CORONARY STENTS MARKET, BY BIOMATERIALS, 2014-2022 ($MILLION)
TABLE 30. LAMEA CORONARY STENTS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 31. ABBOTT: COMPANY SNAPSHOT
TABLE 32. ABBOTT: OPERATING SEGMENTS
TABLE 33. B. BRAUN: COMPANY SNAPSHOT
TABLE 34. B. BRAUN: OPERATING SEGMENTS
TABLE 35. BIOTRONIK: COMPANY SNAPSHOT
TABLE 36. BIOTRONIK: OPERATING SEGMENTS
TABLE 37. BOSTON: COMPANY SNAPSHOT
TABLE 38. BOSTON: OPERATING SEGMENTS
TABLE 39. BARD: COMPANY SNAPSHOT
TABLE 40. BARD: OPERATING SEGMENTS
TABLE 41. MEDTRONIC: COMPANY SNAPSHOT
TABLE 42. MEDTRONIC: OPERATING SEGMENTS
TABLE 43. MICROPORT: COMPANY SNAPSHOT
TABLE 44. MICROPORT: OPERATING SEGMENTS
TABLE 45. STENTYS: COMPANY SNAPSHOT
TABLE 46. STENTYS : OPERATING SEGMENTS
TABLE 47. TERUMO: COMPANY SNAPSHOT
TABLE 48. TERUMO: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. CORONARY STENTS MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS IN GLOBAL CORONARY STENTS MARKET
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. TOP COMPANIES AND NATURE OF THEIR STRATEGIES
FIGURE 7. TOP COMPANIES AND TYPE OF THEIR STRATEGIES
FIGURE 8. MARKET SHARE ANALYSIS: CORONARY STENTS MARKET, 2015
FIGURE 9. BARGAINING POWER OF BUYERS, 2015
FIGURE 10. BARGAINING POWER OF SUPPLIERS, 2015
FIGURE 11. THREAT OF SUBSTITUTES, 2015
FIGURE 12. THREAT OF NEW ENTRANTS, 2015
FIGURE 13. COMPETITIVE RIVALRY, 2015
FIGURE 14. CLINICAL TRIALS FOR CORONARY STENTS (%)
FIGURE 15. GLOBAL CORONARY STENTS MARKET, BY TYPE
FIGURE 16. U.S. CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 17. CANADA CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 18. MEXICO CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 19. GERMANY CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 20. FRANCE CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 21. ITALY CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 22. SPAIN CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 23. REST OF EUROPE CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 24. JAPAN CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 25. CHINA CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 26. INDIA CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 27. AUSTRALIA CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 28. MALAYSIA CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 29. REST OF ASIA-PACIFIC CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 30. BRAZIL CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 31. SOUTH AFRICA CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 32. SOUTH ARABIA CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 33. REST OF LAMEA CORONARY STENTS MARKET, 2014-2022 ($MILLION)

PURCHASE OPTIONS
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT